Eli Lilly Recalls ERBITUX Vials Due to Missing Primary Container Labels
Eli Lilly is recalling 9,380 vials of ERBITUX (cetuximab) because some may be missing primary container labels. The recall covers specific states and Puerto Rico.
- Product
- ERBITUX — ERBITUX (CETUXIMAB)
- Category
- Drug
- Distribution
- 11 states